The calcitonin receptor (CTR) is relevant to three hormonal systems: amylin, calcitonin, and calcitonin gene-related peptide (CGRP). Receptors for amylin and calcitonin are targets for treating obesity, diabetes, and bone disorders. CGRP receptors represent a target for pain and migraine. Amylin receptors (AMY) are a heterodimer formed by the coexpression of CTR with receptor activity-modifying proteins (RAMPs). CTR with RAMP1 responds potently to both amylin and CGRP. The brain stem is a major site of action for circulating amylin and is a rich site of CGRP binding. This study aimed to enhance our understanding of these hormone systems by mapping CTR expression in the human brain stem, specifically the medulla oblongata. Widespread CTR-like immunoreactivity was observed throughout the medulla. Dense CTR staining was noted in several discrete nuclei, including the nucleus of the solitary tract, the hypoglossal nucleus, the cuneate nucleus, spinal trigeminal nucleus, the gracile nucleus, and the inferior olivary nucleus. CTR staining was also observed in the area postrema, the lateral reticular nucleus, and the pyramidal tract. The extensive expression of CTR in the medulla suggests that CTR may be involved in a wider range of functions than currently appreciated. amylin; brain stem; calcitonin gene-related peptide; obesity; migraine THE CALCITONIN RECEPTOR (CTR) is a class B G protein-coupled receptor (GPCR). CTR has roles in a diverse range of physiological functions and is relevant to three distinct hormonal systems: amylin, calcitonin (CT), and calcitonin gene-related peptide (CGRP). Receptors for amylin and calcitonin are targets for treating obesity, diabetes, and bone disorders. CGRP receptors represent a target for pain and migraine. CTR was initially identified in a porcine kidney epithelial cell line and described as a potent receptor for calcitonin (13). However, identifying receptors for amylin and CGRP proved more difficult. The situation became clear when it was shown that CTR could interact with three receptor activity-modifying proteins (RAMPs) (18). Amylin receptors (AMY), which are formed by the coexpression of CTR with RAMP1, RAMP2, or RAMP3 are called AMY 1 , AMY 2 , or AMY 3 , respectively (21). Similarly, the CGRP receptor was found to be formed by coexpression of a distinct GPCR, the calcitonin receptorlike receptor and RAMP1 (17, 21). Interestingly, AMY 1 is also a CGRP receptor, displaying equivalent potency for CGRP and amylin (32).
also a CGRP receptor, displaying equivalent potency for CGRP and amylin (32) .
The brain stem represents an important site of integration for peripheral signals to the nervous system, including the control of food intake, pain perception, and several autonomic functions (9, 22) . Specialized regions of the medulla are involved in distinct physiological functions. The nucleus of the solitary tract (NTS) and the area postrema (AP) are important for controlling food intake (15) . The AP is a sensory circumventricular organ, which is particularly important for the action of circulating hormones, such as amylin. The AP possesses highly fenestrated capillaries, which allow the direct access of circulating hormones to the central nervous system (12) . The cuneate nuclei (Cu) and gracile nuclei (Gr) play roles in proprioception and tactile sensation (15) . The hypoglossal nucleus (12) , the inferior olivary nucleus (IO), and the lateral reticular nucleus (LRt) mediate motor control. The spinal trigeminal nucleus (Sp5) is involved in pain perception (15) .
Currently, there is only limited anatomical information on the expression of CTR in the brain stem. Autoradiography and in situ hybridization techniques have been utilized to indirectly localize CTR to several discrete nuclei (6, 19, 26, 29) . Although several brain stem regions are consistently highlighted as containing CTR, there are regions, including the 12 and IO, that contradict starkly between studies. These apparent contradictions are likely due to the limitations of the methods used. For example, in situ hybridization detects mRNA, which may be produced remotely from the localization of the mature CTR protein. Autoradiography is limited by the binding ability of the modified ligand used, which may not recognize all CTR, amylin, or CGRP receptor subtypes equally. To fully understand the role of CTR, direct detection of CTR protein is required. To date, only a single study has mapped CTR protein expression in the adult rat brain using immunohistochemical techniques (4) . The aim of the current study was to map CTR expression in the human medulla and, thus, enhance our understanding of this receptor in human physiology.
MATERIALS AND METHODS
Postmortem human brain stem was obtained in both New Zealand (five cases) and Europe (three cases). These brains had no history of neurological disease and showed no neurological abnormalities on pathological examination. The age of cases ranged from 65 to 82 years, and the causes of death were ischemic heart disease, hepatitis C, bronchopneumonia, cecal carcinoma, metastatic adenocarcinoma colon, or carcinoma mammae. The cases are the same as used in a previous study, and full details of source, gender, and postmortem delay were previously reported (32). Brain stem samples were pro-cessed and stained as previously described (32) . Briefly, CTR was detected using a monoclonal primary antibody (1:100; 9B4, Welcome Receptor Antibodies Pty. Melbourne, Australia; also available as MCA5749, AbD Serotec, Oxford, UK).
The 9B4 antibody was generated against an extracellular NH2 terminal human CTR sequence [PSEKVTKYCDEKGVWFK] (33) . 9B4 detected bands of ϳ70 and 50 kDa in immunoblots from flipIn-3T3 and Cos-7 cells stably transfected with CTR, consistent with glycosylated and unglycosylated receptors, respectively. Untransfected controls produced no detectable bands (35) . Analogous results were observed using ELISA, immunohistochemistry, and fluorescence-activated cell sorting approaches (33, 35) . We further confirmed 9B4 specificity by ELISA and immunohistochemistry in CTR-transfected HEK-293 cells (23, 32) . HEK-293 cells and Cos-7 cells transfected with a vector control were devoid of detectable CTR mRNA (1, 23) . Correlations between 9B4 staining and CTR mRNA have also been reported in other models, including a chronic myelogenous leukemia cell line (33) . The 9B4 antibody has also been used to detect CTR-positive cells in human cells derived from leukemia and glioblastoma cases (33) (34) (35) . To detect 9B4, different antimouse secondary antibodies were used for 3,3=-diaminobenzidine (1:1,000; B7264, Sigma-Aldrich, St. Louis, MO) or fluorescence (1:200 Alexa Fluor 594; A-11032; Invitrogen) immunostaining. 3,3=-Diaminobenzidine immunostained slides were viewed and imaged using a Leica CLS150X for full-slice imaging or a Nikon Eclipse E800 bright-field microscope. Fluorescence-stained sections were examined using a Nikon 80i light and epifluorescence microscope (Tokyo, Japan) coupled to a Nikon DS-2MV camera. For presentation purposes, images were cropped, and scale bars were moved as appropriate.
In New Zealand, ethical approval was obtained from the University of Auckland Human Participants Ethics Committee, and human brain stems were obtained from the Neurological Foundation of New Zealand Human Brain Bank in the Centre for Brain Research at the University of Auckland. In Europe, the procedures for the human samples were conducted according to the principles outlined in the Declaration of Helsinki and were approved by the local Hungarian Ethics Committee. Human brain stem samples were obtained at autopsy from adult subjects in accordance with the Faculty of Medicine University of Szeged guidelines for ethics in human tissue experiments. None of these subjects had a central nervous system disorder.
RESULTS
Mapping calcitonin receptor in the medulla oblongata. The human brain stem is a complex tissue consisting of several discrete nuclei that can be identified by their location and the architecture of nearby white matter. To confirm the location of specific nuclei in the medulla, Nissl staining of cell bodies was performed in sequential coronal sections from a single brain stem case. Discrete nuclei of the medulla were identified (Fig.  1A) . The AP was only identified in four coronal sections. This bilateral structure lined the floor of the fourth ventricle. Extending beyond the boundaries of the AP and alongside the dorsal motor nucleus of the vagus nerve lies the NTS. The hypoglossal nucleus (12) was identified by characteristic staining of large motor neurons along the midline of the medulla immediately beneath the fourth ventricle floor. Gr and Cu nuclei were both identified lateral to the NTS. The external cuneate nucleus (ECu) was also defined. The IO was identified because of its distinctive structure lateral to the medial lemniscus (ml), which runs along the midline of the medulla. Caudal to this, the LRt was identified. The pyramidal tracts (py) were located on the ventral surface of the medulla. The brain stem cases outlined in this study were previously used to examine CTR staining in the Sp5 and spinal trigeminal tract (sp5) (32) . Sp5 was identified as a column running throughout the entire brain stem in close proximity to the sp5. See Ref. 32 for a description of this staining.
Anatomical mapping of CTR in the medulla was conducted in coronal sections from five New Zealand brain cases using the monoclonal primary antibody 9B4. CTR staining was observed in multiple discrete nuclei from five brain cases examined (Fig. 1, B-G) . In the absence of the primary antibody, negligible background staining was generally observed (Fig. 1G) . Sections from case H196 displayed a greater degree of staining (Fig. 1D) . This was associated with greater nonspecific background staining in this case. The higher-magnification DAB-stained images described below were taken from case H160 (Figs. 2 and 3) . To confirm the findings observed in DAB-stained medulla from New Zealand, a second cohort of human cases from Europe were examined using the same primary antibody (9B4) and detected using an immunofluorescent secondary antibody (Figs. 2 and 3) .
Calcitonin receptor expression in the area postrema and nucleus of the solitary tract. Because of the potential importance of the AP in amylin-mediated control of feeding behavior, this region and the underlying NTS were investigated in detail. The AP was identified because of its characteristic highly vascularized sponge-like appearance in cases H160 and H187. Intense staining was observed in the AP (Fig. 2, A and  B) . Although staining of cell bodies was not discernible, neuropils were stained in this region (Fig. 2, A and B) . AP could not be conclusively defined in the remaining DAB sections or in any immunofluorescence-stained sections. This was not surprising, given the small number of sections that contain AP and the difficulty distinguishing AP from the underlying NTS. The densest staining of any medulla nuclei was observed in the NTS. This staining was almost exclusively present in neuropil (Fig. 2, B and C) . To confirm the pattern of CTR expression observed, immunofluorescence was performed in a second cohort of cases. To ensure a similar region of the medulla was examined, hematoxylin staining was performed on adjacent sections, and the appropriate region was selected (Fig. 2D) . CTR staining was observed in neuropil of the NTS, confirming initial observations (Fig. 2E) . A filter change revealed some autofluorescence in these sections, likely due to lipofuscin (Fig. 2F) . Similar patterns of staining were observed in the NTS from a more rostral brain stem section (Fig. 2, G and H) and at higher magnification (Fig. 2I) . . D: hematoxylinstained coronal section (case 109) identifying the approximate area (E-F) examined in an adjacent section (black box). E: using a red fluorescent secondary antibody, CTR staining was also observed in neuropil in the NTS. F: some autofluorescent lipofuscin was identified in sections stained with a fluorescent secondary by changing to the green filter. G: hematoxylin-stained coronal section (case 109) identifying the approximate area (H) examined in an adjacent section (black box). H-I: using a red fluorescent secondary CTR, staining was observed in neuropil in the NTS. CTR-like immunoreactivity is shown in brown (DAB) or red (immunofluorescence). Open arrowhead, autofluorescence (lipofucsin).
Calcitonin receptor expression in other medulla oblongata nuclei. Several discrete nuclei stained positively for CTR beyond the AP and NTS. In the Gr, there was CTR staining in both cell bodies and neuropil (Fig. 3A) . This was confirmed using a fluorescently labeled secondary antibody (Fig. 3B) ; however, substantial autofluorescence was also present (Fig.  3C) . Intense staining for CTR was found in the cell bodies of the Cu with moderate staining of the neuropil (Fig. 3D) . A similar pattern of staining emerged when using a fluorescently labeled secondary antibody (Fig. 3E) , with some autofluorescence in this section (Fig. 3F) . The Cu had generally the highest levels of background staining in the brain stem. CTR staining in the ECu was also observed in both cell bodies and neuropil (Fig. 3G) . Strong staining for CTR in 12 was detected in the neuropil with moderate staining in cell bodies (Fig. 3H) . Some CTR-stained neuropil were seen in the medial longitudinal fasciculus (mlf) (Fig. 3I) . The IO displayed strong staining for CTR in neuropil with some small moderately stained immunopositive cell bodies (Fig. 3J) . A small number of CTR-stained neuropil were seen in the LRt and py (Fig. 3, K and L). Immunolabeling of CTR was also observed in the Sp5, as previously described (32) .
DISCUSSION
In the central and peripheral nervous system CT, amylin and CGRP have been reported to have a wide range of physiological effects, including the modulation of feeding behavior and control of pain perception (10) . The receptors for these hormones are proven clinical targets; salmon CT is used to treat bone disorders, such as osteoporosis (5), and the amylin mimetic pramlintide is approved by the U.S. Food and Drug Administration for the treatment of Type 1 diabetes (10). This has helped the ongoing clinical development of agonists and antagonists targeting these systems. New formulations and variations of CT and amylin-based therapies are actively being developed for the treatment of bone disorders and obesity (10, 16) . CGRP receptor antagonists are actively being developed for the treatment of migraine (8) . Defining the precise localization of the CTR is essential for future clinical development for all of these peptide systems.
This study represents the first complete report of CTR protein expression in the human medulla oblongata. CTR-like immunoreactivity was observed throughout the medulla, with dense CTR staining noted in several discrete nuclei, including the NTS, 12, Cu, Sp5, Gr, and IO. This extensive expression of CTR in the medulla may indicate that CTR is involved in a wider range of functions than is currently appreciated. The pattern of CTR observed in the human medulla overlapped with that reported previously in adult and neonatal rat medulla. Interestingly, in rat medulla, no CTR-like immunoreactivity was reported in Gr, 12, or IO (4, 29) . Contradicting these findings, a separate study reported specific amylin binding in these brain stem regions (28) . Similarly, in monkey brain, either CT and/or amylin binding was noted in the Gr, 12, or IO (20) . The subtle differences observed between the current and previous immunohistochemical studies may reflect species or methodological differences. For example, the current study utilized a monoclonal antibody directed against the extracellular NH 2 terminus of human CTR, whereas the polyclonal antibody used by Becskei et al. (4) recognizes an intracellular epitope. Furthermore, in the current study, antigen retrieval was employed, which dramatically enhanced the ability to detect CTR. The ability of different antibodies to detect CTR may also be altered by the splice variant or the presence of accessory proteins. Association with RAMP1 has been shown to partially mask the detection of CTR in a cell culture amylin receptor model (23) . Overall, the pattern of CTR-like immunoreactivity we report herein concurs with pattern of CT or amylin binding and displays considerable overlap with CGRP binding reported previously (20, 27, 28) . This suggests that CTR is likely the core GPCR required for CT and amylin binding in the brain stem. CGRP binding may also involve CTR.
The densest staining for CTR observed was localized to the region encompassing the AP and NTS. This corresponds to the well-characterized physiological action of amylin in the AP to reduce food intake (10) . The AP is a highly vascularized circumventricular organ that is outside the blood-brain barrier (BBB) and thus, accessible to circulating hormones (12) . A series of elegant experiments involving ablation of the AP showed its importance for amylin action and that these effects could be mimicked by salmon CT and CGRP (10) . Similar results have been observed for the modulation of drinking behavior by amylin and CT in another circumventricular organ, the subfornical organ (24, 25) . However, given the density of CTR staining and amylin binding, the contribution of the underlying NTS in modulating feeding behavior should not be overlooked. Circulating amylin is reported to have free, but limited, ability to cross the BBB (3). An apparent transportermediated process was shown to transfer amylin (ϳ0.12% of an injected dose) into the brain, with preferential uptake into the medulla and cerebellum (3) . Similar studies have suggested that CT is unable to cross the BBB (2). Interestingly, it should be noted that CGRP expression has been reported extensively throughout the brain stem, including in the NTS, AP, 12, IO, LRt, Cu, ECu, and Sp5 (7, 31) . This suggests that CGRP may activate CTR in these regions. However, consistent with the pharmacology of amylin receptor subtypes, it has been noted that CGRP and amylin binding have both overlapping and specific elements (6, 11) .
The observation of CTR staining in cell bodies and neuropil of 12 is particularly intriguing, given the involvement of amylin in the control of feeding behavior. These cell bodies may be motor neurons, which control movement of the tongue and are activated during licking and swallowing (30) . It is possible that CTR and amylin may play a direct role in motor control during feeding. Similarly, the IO has been implicated in voluntary movement, and the Cu and Gr play roles in proprioception (14) . These findings suggest that CTR in the brain stem may play a role in the integration of sensory and motor activities. In future studies, further characterization of the cell bodies expressing CTR in these regions should be undertaken to determine whether they are motor neurons.
Perspectives and Significance
The mapping of CTR protein in the human brain stem has revealed that the CTR may potentially be involved in a more complex array of functions than previously appreciated. This finding opens new, yet complementary, avenues of research to understand the role of CTR and its agonists: amylin, CT, and CGRP in the brain stem. In future studies, coexpression of the CTR should be examined with accessory proteins (e.g., RAMPs) and potential agonists, together with neuronal markers.
